Surface plasmon resonance reveals a different pattern of proinsulin autoantibodies concentration and affinity in diabetic patients

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Trabucchi, Aldana ^a   Guerra, Luciano L ^a   Faccinetti, Natalia I ^a   Iacono, Rubén F ^a   Poskus, Edgardo ^a   Valdez, Silvina N ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HYBRID PROTEIN; PROINSULIN; PROINSULIN AUTOANTIBODY; RECOMBINANT ANTIGEN; THIOREDOXIN; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; ANTIBODY AFFINITY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BIOSENSOR; CHEMOLUMINESCENCE; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMORAL IMMUNITY; IMMOBILIZED CELL; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; PROTEIN IMMOBILIZATION; QUANTITATIVE ANALYSIS; RADIOASSAY; REPRODUCIBILITY; SURFACE PLASMON RESONANCE; TECHNOLOGY; ADULT; BLOOD; CLINICAL TRIAL; FEMALE; IMMUNOLOGY; MALE; MULTICENTER STUDY; PRESCHOOL CHILD;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY AFFINITY; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; PROINSULIN; SURFACE PLASMON RESONANCE;

EID: 84858609388     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033574     Document Type: Article

References (33)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197.
2. Atkinson MA, Eisenbarth GS, (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358: 221-229.
3. Ziegler AG, Hummel M, Schenker M, Bonifacio E, (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48: 460-468.
4. Kimpimaki T, Kulmala P, Savola K, Kupila A, Korhonen S, et al. (2002) Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 87: 4572-4579.
5. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, et al. (2000) Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 97: 1701-1706.
6. Colman PG, Steele C, Couper JJ, Beresford SJ, Powell T, et al. (2000) Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody. Diabetologia 43: 203-209.
7. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, et al. (2007) The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 104: 17040-17045.
8. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler A-G, et al. (2004) Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 114: 589-597.
9. Mire-Sluis AR, Barrett YC, Devanarayan V, Koren E, Liu H, et al. (2004) Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J Immunol Methods 289: 1-16.
10. Sodoyez-Goffaux F, Koch M, Dozio N, Brandenburg D, Sodoyez JC, (1988) Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies. Diabetologia 31: 694-702.
11. Ayela C, Roquet F, Valera L, Granier C, Nicu L, et al. (2007) Antibody-antigenic peptide interactions monitored by SPR and QCM-D. A model for SPR detection of IA-2 autoantibodies in human serum. Biosens Bioelectron 22: 3113-3119.
12. Carlsson J, Gullstrand C, Westermark GT, Ludvigsson J, Enander K, et al. (2008) An indirect competitive immunoassay for insulin autoantibodies based on surface plasmon resonance. Biosens Bioelectron 24: 882-887.
13. Trabucchi A, Guerra LL, Faccinetti NI, Iacono RF, Poskus E, et al. (2011) Expression and characterization of human proinsulin fused to thioredoxin in Escherichia coli. AMAB In press.
14. Valdez SN, Sica MP, Labovsky V, Iacono RF, Cardoso AL, et al. (2001) Combined measurement of diabetes mellitus immunological markers: an assessment of its benefits in adult-onset patients. Autoimmunity 33: 227-236.
15. Caputo M, Cerrone GE, Lopez AP, Villalba A, Krochik GA, et al. (2005) Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults. (LADA) 38: 277-281.
16. (1985) Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 727: 1-113.
17. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC, (1998) UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 15: 297-303.
18. Valdez SN, Iacono RF, Villalba A, Cardoso_Landaburu A, Ermacora MR, et al. (2003) A radioligand-binding assay for detecting antibodies specific for proinsulin and insulin using 35S-proinsulin. J Immunol Methods 279: 173-181.
19. Berzofsky JA, Schechter AN, (1981) The concepts of crossreactivity and specificity in immunology. Mol Immunol 18: 751-763.
20. Johnsson B, Lofas S, Lindquist G, (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 198: 268-277.
21. Berzofsky JA, Berkower IJ, Epstein SL, (1993) Antigen-Antibody Interactions and Monoclonal Antibodies. In: Paul WE, editors. Fundamental Immunology. 3ra ed New York Raven Press pp. 421-465.
22. Winter J, Neubauer P, Glockshuber R, Rudolph R, (2000) Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA. J Biotechnol 84: 175-185.
23. Pihoker C, Gilliam LK, Hampe CS, Lernmark A, (2005) Autoantibodies in diabetes. Diabetes 54 (Suppl 2): S52-61.
24. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG, (2005) Natural history of type 1 diabetes. Diabetes 54 (Suppl 2): S25-31.
25. Sabbah E, Savola K, Kulmala P, Veijola R, Vahasalo P, et al. (1999) Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group. J Clin Endocrinol Metab 84: 1534-1539.
26. Strebelow M, Schlosser M, Ziegler B, Rjasanowski I, Ziegler M, (1999) Karlsburg Type I diabetes risk study of a general population: frequencies and interactions of the four major Type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 42: 661-670.
27. Kupila A, Keskinen P, Simell T, Erkkila S, Arvilommi P, et al. (2002) Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 51: 646-651.
28. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, et al. (1994) Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 37: 1113-1120.
29. Borg H, Gottsater A, Fernlund P, Sundkvist G, (2002) A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51: 1754-1762.
30. Burnet FM, (1961) The new approach to immunology. N Engl J Med 264: 24-34.
31. Wabl M, Cascalho M, Steinberg C, (1999) Hypermutation in antibody affinity maturation. Curr Opin Immunol 11: 186-189.
32. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, et al. (2004) Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 140: 882-886.
33. Bohmer K, Keilacker H, Kuglin B, Hubinger A, Bertrams J, et al. (1991) Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia 34: 830-834.